Analyst Moves: AMGN, FCX, AVP

Market News Video
May 01, 2013 AT 11:35 AM
This morning, Goldman Sachs upgraded shares of Amgen (AMGN) from neutral to buy as near-term catalysts could propel the stock higher. With the upgrade, Goldman set a $130 price target and added the stock to its Conviction Buy List.